Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Otis W. Brawley"'
Autor:
Ahmedin Jemal, Otis W. Brawley, Stacey A. Fedewa, Kevin J. Cullen, J. Leonard Lichtenfeld, Farhad Islami, Richard C. Wender, Jiemin Ma
Publikováno v:
CA: A Cancer Journal for Clinicians. 69:351-362
A summary evaluation of the 2015 American Cancer Society (ACS) challenge goal showed that overall US mortality from all cancers combined declined 26% over the period from 1990 to 2015. Recent research suggests that US cancer mortality can still be lo
Autor:
Lauren R. Teras, Eric J. Jacobs, Otis W. Brawley, Jeffrey Drope, Clifford E Douglas, Alpa V. Patel, Richard C. Wender, Susan M. Gapstur, Marjorie L. McCullough
Publikováno v:
CA: A Cancer Journal for Clinicians. 68:446-470
In the United States, it is estimated that more than 1.7 million people will be diagnosed with cancer, and more than 600,000 will die of the disease in 2018. The financial costs associated with cancer risk factors and cancer care are enormous. To sub
Autor:
Kevin Stein, Steven B. Clauser, Neeraj K. Arora, Ryan McCabe, Otis W. Brawley, Alyssa N. Troeschel, Joseph Lipscomb, Tenbroeck Smith, Kathleen Castro, Elizabeth Ward
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37(19)
PURPOSE Pain, fatigue, and distress are common among patients with cancer but are often underassessed and undertreated. We examine the prevalence of pain, fatigue, and emotional distress among patients with cancer, as well as patient perceptions of t
Autor:
Neha Malik, Christopher R. Flowers, Kevin C. Ward, Rajni Sinha, Otis W. Brawley, Ajay K. Nooka, Joseph Lipscomb, Pareen J. Shenoy
Publikováno v:
Cancer. 117:2530-2540
Diffuse large B-cell lymphoma (DLBCL) is often cured with standard chemoimmunotherapy, but there is great heterogeneity in presentation and outcomes.By using Surveillance, Epidemiology, and End Results (SEER) data from 13 registries across the United
Autor:
Otis W. Brawley, Edward L. Trimble, Richard Ungerleider, M Smith, Nancy Breen, Warren B. Sateren, Leslie G. Ford, Jeffrey Abrams, Mary S. McCabe, Michaele C. Christian, Richard Kaplan
Publikováno v:
Journal of Clinical Oncology. 20:2109-2117
PURPOSE: We chose to examine the impact of socioeconomic factors on accrual to National Cancer Institute (NCI)–sponsored cancer treatment trials. PATIENTS AND METHODS: We estimated the geographic and demographic cancer burden in the United States a
Autor:
Timothy J. Key, Lori M. Minasian, Zoran Culig, Bernd J. Schmitz-Dräger, Fritz H. Schröder, Jack A. Schalken, Freddie C. Hamdy, Jack Cuzick, Lars Holmberg, Rosalind A. Eeles, Powel H. Brown, Sven Perner, Harry G. Rittenhouse, Frank L. Meyskens, Howard L. Parnes, Bertrand Tombal, Hans-Peter Schmid, Timothy J Wilt, Michael Marberger, Arnulf Stenzl, Hans Lilja, Leslie G. Ford, Mangesh A. Thorat, Carlo La Vecchia, Chris Parker, Alicja Wolk, Otis W. Brawley, Gerald L. Andriole, Dragan Ilic
Publikováno v:
Lancet Oncology, 15, e484-92
Cuzick, J; Thorat, MA; Andriole, G; Brawley, OW; Brown, PH; Culig, Z; et al.(2014). Prevention and early detection of prostate cancer. The Lancet Oncology, 15(11), e484-e492. doi: 10.1016/S1470-2045(14)70211-6. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/99829759
Lancet Oncology, 15(11), E484-E492. Lancet Publishing Group
Lancet Oncology, 15, 11, pp. e484-92
Cuzick, J; Thorat, MA; Andriole, G; Brawley, OW; Brown, PH; Culig, Z; et al.(2014). Prevention and early detection of prostate cancer. The Lancet Oncology, 15(11), e484-e492. doi: 10.1016/S1470-2045(14)70211-6. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/99829759
Lancet Oncology, 15(11), E484-E492. Lancet Publishing Group
Lancet Oncology, 15, 11, pp. e484-92
Contains fulltext : 139211.pdf (Publisher’s version ) (Closed access) Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d367cd74ea13c1e896ee7cacb739af
http://hdl.handle.net/2066/139211
http://hdl.handle.net/2066/139211
Publikováno v:
American Journal of Clinical Oncology: Cancer Clinical Trials. 23:107-116
Between 1972 and 1988, more than 500 women were treated for ovarian cancer at the National Cancer Institute in Bethesda, Maryland on approved experimental treatment protocols. Of these, 73 underwent autopsy evaluation on the National Cancer Institute
Publikováno v:
Archives of Family Medicine. 8:521-528
OBJECTIVE To investigate why breast cancer mortality rates have decreased in the 1990's for white women but not for black women. DESIGN Racial differences in breast cancer incidence, survival, and mortality rates were examined using regression method
Autor:
Otis W. Brawley
Publikováno v:
World journal of urology. 30(2)
Prostate cancer is a significant public health issue in the United States. It is the most commonly diagnosed non-skin cancer and the second leading cause of cancer death. The American Cancer Society estimates that in 2011, 240,890 men were diagnosed
Autor:
Curtis A. Pettaway, Otis W. Brawley, Roger S. Rittmaster, Leonard G. Gomella, Teuvo L.J. Tammela, Stephen J. Freedland, Gerald L. Andriole, Francesco Montorsi, Timothy Wilson, Ramiro Castro, Michael Marberger, Claudio Teloken, Ivy L. Fowler, Matthew C. Somerville, David Bostwick, Donald J. Tindall
Purpose: We assessed whether dutasteride enhances the usefulness of total prostate specific antigen for diagnosing clinically significant prostate cancer. Materials and Methods: The 4-year REDUCE study evaluated the efficacy and safety of 0.5 mg duta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6975e9421d98c1a2548fdf77822295